At a glance
- Originator Takeda
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 13 Oct 2000 Discontinued-Preclinical for HIV infections treatment in Japan (Unknown route)
- 12 Jun 2000 Profile reviewed but no significant changes made
- 14 Jul 1998 No-Development-Reported for HIV infections treatment in Japan (Unknown route)